Gabriele Ghirlanda is the new Global Access & Value Director of Angelini Pharma. He is the successor of Fabio De Luca, Global Marketing Head, who led the Global Access directorate on an interim basis. In his role, Ghirlanda reports directly to CEO Pierluigi Antonelli and joins the Executive Leadership Team, the Company's Steering Committee.
"I am really glad that Gabriele joined our team: a young and brilliant professional with a solid experience in Market Access. He will play a relevant, strategic role for our sector by looking at the investments that our Group is planning to make in the fields of Mental Health, Rare Diseases and Self-Medication".
Pierluigi Antonelli, CEO Angelini Pharma
After three years at Boehringer, Ghirlanda joined Bayer in 2014 working at the company's German headquarters and taking on the role of Global Pricing & Reimbursement Manager for the Gynecology, Cardio-Metabolic and Oncology areas. In 2016, he moved to the United States as deputy director Strategic Pricing and Reimbursement for the same directorates. Subsequently, in Japan, he held the position of Head of Market Access – Cardiovascular & Pricing.
Gabriele Ghirlanda, born in 1985, PhD in Management (innovation, sustainability and healthcare) at the Scuola Superiore di Alta Formazione e di Perfezionamento Sant'Anna in Pisa, holds a Master's Degree in Public Administration and an MBA in Healthcare and Pharmaceutical Administration from the Luiss University in Rome.